News
Market and company headlines
HSICAll
Loading
06:00Oct 201 Story
14:00Oct 191 Story
06:00Oct 161 Story
12:00Oct 141 Story
03:00Oct 91 Story
04:00-08:00Oct 82 Stories
Henry Schein Announces Chief Financial Officer Leadership Transition
MELVILLE, N.Y., October 08, 2026--Henry Schein, Inc. (Nasdaq: HSIC) announced today that Emmanuel Caprais, former Senior Vice President and Chief Financial Officer of ITT, Inc. (NYSE: ITT), has been named the Company’s Senior Vice President and Chief Financial Officer effective November 4, 2026. Mr. Caprais will join the Henry Schein Leadership Team (HSLT) and report to Frederick M. Lowery, Chief Executive Officer of Henry Schein. To support a structured transition, Mr. Caprais will initially se
3 Low-Volatility Stocks with Open Questions
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
08:00-11:00Oct 62 Stories
HSIC or MMSI: Which Is the Better Value Stock Right Now?
HSIC vs. MMSI: Which Stock Is the Better Value Option?
Should Value Investors Buy Henry Schein (HSIC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
04:00Oct 11 Story
06:00-12:00Sep 302 Stories
Cardinal Health: I'm Still Buying After Checking The Numbers
Cardinal Health remains a Buy, driven by robust FY2026 results, strong cash flow, and credible FY2027 guidance. Read more on CAH stock here.
Henry Schein Cares Marks 25 Years of Helping Health Happen®
MELVILLE, N.Y., September 30, 2026--Henry Schein Cares, Henry Schein, Inc.’s global corporate citizenship program, is celebrating a quarter century of bringing together Team Schein Members, customers, supplier partners, healthcare professionals, nonprofit organizations, and communities to help make the world healthier.
13:00Sep 281 Story
04:00Sep 271 Story
06:00Sep 261 Story
01:00-06:00Sep 252 Stories
Is Henry Schein Stock Outperforming the Dow?
Henry Schein has outperformed the Dow over the past year, and analysts are cautiously optimistic about the stock’s prospects.
Transcript: Henry Schein Q2 2026 Earnings Conference Call
Henry Schein (NASDAQ:HSIC) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and
04:00Sep 231 Story
02:00Sep 191 Story
09:00Sep 181 Story
11:00-13:00Sep 162 Stories
What Makes Henry Schein (HSIC) a New Buy Stock
Henry Schein (HSIC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
HSIC or SAUHY: Which Is the Better Value Stock Right Now?
HSIC vs. SAUHY: Which Stock Is the Better Value Option?
06:00Sep 161 Story
14:00Sep 151 Story
08:00Sep 91 Story
09:00Aug 201 Story
02:00-05:00Aug 192 Stories
Palo Alto To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts changed outlook on top names. Piper Sandler raises Mercury Systems' target price, Ascendiant Capital boosts Alzamend Neuro's target price, BTIG raises Henry Schein's target price, Cantor Fitzgerald increases Palo Alto's target price, Morgan Stanley cuts Baidu's target price, Cantor Fitzgerald slashes Crowdstrike Holdings' target price, Baird raises Donaldson Company's target price, B of A Securities cuts Pony AI's target price.
BTIG Maintains Buy on Henry Schein, Raises Price Target to $110
BTIG analyst David Larsen maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises the price target from $100 to $110.
05:00-10:00Aug 182 Stories
HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates
Henry Schein's stronger Q2 sales and margins prompt a 2026 outlook hike, but second-half savings execution remains key to sustaining earnings momentum.
3 Unpopular Stocks with Open Questions
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
11:00Aug 171 Story
04:00Aug 131 Story
12:00Aug 111 Story
09:00Aug 101 Story
05:00-12:00Aug 62 Stories
HSIC or SAUHY: Which Is the Better Value Stock Right Now?
HSIC vs. SAUHY: Which Stock Is the Better Value Option?
Barclays Maintains Overweight on Henry Schein, Raises Price Target to $100
Barclays analyst Glen Santangelo maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $86 to $100.
11:00-22:00Aug 52 Stories
Should Henry Schein’s Raised 2026 Sales Growth Guidance Require Action From Henry Schein (HSIC) Investors?
Henry Schein, Inc. reported past Q2 2026 results with sales rising to US$3,458 million and net income to US$94 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. Importantly for long-term watchers, management also raised its 2026 total sales growth guidance, signaling greater confidence in the company’s operating initiatives and demand trends. Now we’ll examine how Henry Schein’s raised 2026 sales outlook reshapes its existing...
UBS Maintains Neutral on Henry Schein, Raises Price Target to $94
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $89 to $94.